These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8800182)

  • 1. Thrombin generation with heparin-bonded cardiopulmonary bypass circuits.
    Bannan S; Martin PG
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):849. PubMed ID: 8800182
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.
    Ernofsson M; Thelin S; Siegbahn A
    Scand J Thorac Cardiovasc Surg; 1995; 29(4):157-65. PubMed ID: 8789468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.
    Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
    Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P
    Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
    Olsson C; Siegbahn A; Haldén E; Nilsson B; Venge P; Thelin S
    Ann Thorac Surg; 2000 Mar; 69(3):743-9. PubMed ID: 10750754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low heparinization with heparin-bonded bypass circuits: is it a safe strategy?
    Bannan S; Danby A; Cowan D; Ashraf S; Martin PG
    Ann Thorac Surg; 1997 Mar; 63(3):663-8. PubMed ID: 9066381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?].
    Meyer D; Tsakiris DA; Marbet GA
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1352-4. PubMed ID: 2678451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low heparinization and heparin-bonded circuits.
    Hill RC
    Ann Thorac Surg; 1997 Oct; 64(4):1221-2. PubMed ID: 9354574
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass.
    von Segesser LK
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):200-1. PubMed ID: 11174722
    [No Abstract]   [Full Text] [Related]  

  • 15. Con: heparin-bonded cardiopulmonary bypass circuits do not represent a desirable and cost-effective advance in cardiopulmonary bypass technology.
    Woolf RL; Mythen MG
    J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):710-2. PubMed ID: 9854674
    [No Abstract]   [Full Text] [Related]  

  • 16. Pro: heparin-bonded circuits represent a desirable option for cardiopulmonary bypass.
    Shore-Lesserson L
    J Cardiothorac Vasc Anesth; 1998 Dec; 12(6):705-9. PubMed ID: 9854673
    [No Abstract]   [Full Text] [Related]  

  • 17. Pro and con of heparin-bonded circuits for cardiopulmonary bypass.
    Weiss BM; von Segesser LK
    J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):646-52. PubMed ID: 10527241
    [No Abstract]   [Full Text] [Related]  

  • 18. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S; Hiramatsu Y; Matsuzaki K; Goto Y; Sato S; Abe M; Kato H; Matsubara M; Sakakibara Y
    J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.
    Ernofsson M; Thelin S; Siegbahn A
    J Thorac Cardiovasc Surg; 1997 Mar; 113(3):576-84. PubMed ID: 9081105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiopulmonary bypass over 24 hours without systemic anticoagulation: new horizons?].
    von Segesser LK; Turina M
    Helv Chir Acta; 1990 Oct; 57(2):389-93. PubMed ID: 2074206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.